Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial

Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No significant changes to core study information; only presentational/UI adjustments are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-30T12:03:47.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Version label updated from v3.0.2 to v3.2.0.
    Difference
    0.1%
    Check dated 2025-10-01T03:58:27.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Upgrade of the page version from v3.0.2 to v3.1.0; a metadata/versioning change with no impact on core content or user-facing data.
    Difference
    0.1%
    Check dated 2025-09-30T03:08:41.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2 and the 'Back to Top' link was removed. Overall, no substantive changes to core content are evident.
    Difference
    0.2%
    Check dated 2025-09-15T19:33:43.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-08T15:07:09.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies related to renal cell carcinoma. Notably, the previous version's specific terms and classifications related to antineoplastic agents have been removed.
    Difference
    3%
    Check dated 2025-09-01T09:40:19.000Z thumbnail image

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.